Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SIRPB1 antibody (AA 30-371) (FITC)

The Rabbit Polyclonal anti-SIRPB1 antibody has been validated for . It is suitable to detect SIRPB1 in samples from Human.
Catalog No. ABIN7169709

Quick Overview for SIRPB1 antibody (AA 30-371) (FITC) (ABIN7169709)

Target

See all SIRPB1 Antibodies
SIRPB1 (Signal-Regulatory Protein beta 1 (SIRPB1))

Reactivity

  • 37
  • 3
  • 1
  • 1
Human

Host

  • 32
  • 7
Rabbit

Clonality

  • 33
  • 6
Polyclonal

Conjugate

  • 21
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SIRPB1 antibody is conjugated to FITC

Application

Please inquire
  • Binding Specificity

    • 7
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 30-371

    Purpose

    SIRPB1 Antibody, FITC conjugated

    Purification

    Protein G purified

    Purity

    >95 %

    Immunogen

    Recombinant Human Signal-regulatory protein beta-1 protein (30-371AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    SIRPB1 (Signal-Regulatory Protein beta 1 (SIRPB1))

    Alternative Name

    SIRPB1

    Background

    Background: Immunoglobulin-like cell surface receptor involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. Participates also in the recruitment of tyrosine kinase SYK.

    Aliases: SIRPB1 antibody, Signal-regulatory protein beta-1 antibody, SIRP-beta-1 antibody, CD172 antigen-like family member B antibody, CD antigen CD172b antibody

    UniProt

    O00241
You are here:
Chat with us!